{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:31:21Z","timestamp":1792434681796,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109335","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T11:47:57Z","timestamp":1668685677000},"page":"109335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-9746","authenticated-orcid":false,"given":"Satoshi","family":"Deyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109335_bib1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopsych.2007.09.019","article-title":"Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy","volume":"63","author":"Adachi","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S1461145709000248","article-title":"Gender differences in the enhanced vulnerability of BDNF+\/- mice to mild stress","volume":"12","author":"Advani","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.mp.4001464","article-title":"Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression","volume":"9","author":"Alonso","year":"2004","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/mp.2010.119","article-title":"Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models","volume":"17","author":"Andrus","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109335_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2022.01.104","article-title":"mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression","volume":"303","author":"Averill","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2202-13-125","article-title":"Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?","volume":"13","author":"Barreto","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2011.318","article-title":"BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity","volume":"37","author":"Bath","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109335_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2018.12.022","article-title":"Resilience Is associated with larger dentate gyrus, while suicide decedents with major depressive disorder have fewer granule neurons","volume":"85","author":"Boldrini","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/npp.2013.5","article-title":"Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression","volume":"38","author":"Boldrini","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0006-3223(01)01280-X","article-title":"Volumetric reduction in left subgenual prefrontal cortex in early onset depression","volume":"51","author":"Botteron","year":"2002","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv101","article-title":"Insulin-like growth factor I produces an antidepressant-like effect and elicits N-methyl-D-aspartate receptor independent long-term potentiation of synaptic transmission in medial prefrontal cortex and hippocampus","volume":"19","author":"Burgdorf","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng1395","article-title":"VEGF links hippocampal activity with neurogenesis, learning and memory","volume":"36","author":"Cao","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2022.109335_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep11252","article-title":"A key role for TGF-beta1 in hippocampal synaptic plasticity and memory","volume":"5","author":"Caraci","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109335_bib21","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/s41386-018-0117-6","article-title":"Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression","volume":"43","author":"Carboni","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109335_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109335_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1129663","article-title":"Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109335_bib25","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib26","doi-asserted-by":"crossref","first-page":"16481","DOI":"10.1073\/pnas.0902833106","article-title":"Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation","volume":"106","author":"Chiaruttini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbadis.2016.04.001","article-title":"Hippocampal VEGF is necessary for antidepressant-like behaviors but not sufficient for antidepressant-like effects of ketamine in rats","volume":"1862","author":"Choi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.109335_bib28","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.109335_bib29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0006-3223(02)01457-9","article-title":"Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis","volume":"52","author":"Czeh","year":"2002","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2018.03.057","article-title":"Antidepressant effects of acupoint stimulation and fluoxetine by increasing dendritic arborization and spine density in CA1 hippocampal neurons of socially isolated rats","volume":"675","author":"Davila-Hernandez","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biopsych.2018.12.014","article-title":"Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor","volume":"86","author":"Deyama","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2018.17121368","article-title":"Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine","volume":"176","author":"Deyama","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172837","article-title":"Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine","volume":"188","author":"Deyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109335_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112844","article-title":"The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice","volume":"394","author":"Deyama","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41398-022-01943-9","article-title":"IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine","volume":"12","author":"Deyama","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euroneuro.2019.11.002","article-title":"Neuron-specific deletion of VEGF or its receptor Flk-1 impairs recognition memory","volume":"31","author":"Deyama","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jphs.2021.05.002","article-title":"Resolvins as potential candidates for the treatment of major depressive disorder","volume":"147","author":"Deyama","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/386824a0","article-title":"Subgenual prefrontal cortex abnormalities in mood disorders","volume":"386","author":"Drevets","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109335_bib41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbr.2008.11.016","article-title":"Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise","volume":"198","author":"Duman","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109335_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ejn.14630","article-title":"Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants","volume":"53","author":"Duman","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpsychires.2009.03.008","article-title":"Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains","volume":"43","author":"Dunham","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","article-title":"Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects","volume":"60","author":"Dwivedi","year":"2003","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuroscience.2005.12.058","article-title":"Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone","volume":"139","author":"Dwivedi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109335_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109335_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2010.02.063","article-title":"Differential brain, but not serum VEGF levels in a genetic rat model of depression","volume":"474","author":"Elfving","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archpsyc.64.4.410","article-title":"Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression","volume":"64","author":"Frodl","year":"2007","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mp.2008.143","article-title":"Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety","volume":"14","author":"Gatt","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib53","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109335_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib55","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/npp.2009.68","article-title":"Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization","volume":"34","author":"Greene","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2016.08.008","article-title":"Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition","volume":"72","author":"Grieco","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature15257","article-title":"Labelling and optical erasure of synaptic memory traces in the motor cortex","volume":"525","author":"Hayashi-Takagi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109335_bib58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2021.03.073","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes","volume":"290","author":"Heerlein","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1460-9568.2005.03951.x","article-title":"Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression","volume":"21","author":"Heine","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2007.09.053","article-title":"The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers","volume":"429","author":"Hilt","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2014.4761","article-title":"The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease","volume":"72","author":"Hohman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109335_bib63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2005.01.007","article-title":"Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects","volume":"1037","author":"Hoshaw","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020198","article-title":"Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex","volume":"6","author":"Howell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109335_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopsych.2013.01.005","article-title":"Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study","volume":"74","author":"Huang","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib66","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/tp.2012.123","article-title":"Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters","volume":"2","author":"Isung","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib67","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2016.03.033","article-title":"Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity","volume":"165","author":"Jais","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109335_bib68","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","article-title":"Decreased expression of synapse-related genes and loss of synapses in major depressive disorder","volume":"18","author":"Kang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109335_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","article-title":"Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs","volume":"136","author":"Karege","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib70","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/mp.2017.220","article-title":"BDNF release and signaling are required for the antidepressant actions of GLYX-13","volume":"23","author":"Kato","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib71","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1172\/JCI126859","article-title":"Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation","volume":"129","author":"Kato","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109335_bib72","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cellsig.2007.12.009","article-title":"Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium\/calmodulin protein kinase II and mammalian target of rapamycin","volume":"20","author":"Kim","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2022.109335_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109335_bib75","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuroscience.2012.01.023","article-title":"Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice","volume":"207","author":"Kiuchi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109335_bib76","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/mp.2017.87","article-title":"A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects","volume":"23","author":"Kondo","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2019.04.080","article-title":"Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study","volume":"253","author":"Kranaster","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib78","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fnagi.2017.00365","article-title":"Insulin-like growth factor-1 and neuroinflammation","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib80","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2012.05.031","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients","volume":"72","author":"Laje","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib81","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1471-4159.2002.01085.x","article-title":"Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice","volume":"82","author":"Lee","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109335_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4062\/biomolther.2019.152","article-title":"Imipramine ameliorates depressive symptoms by bocking differential alteration of dendritic spine structure in amygdala and prefrontal cortex of chronic stress-induced mice","volume":"28","author":"Leem","year":"2020","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.neuropharm.2022.109335_bib83","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2016.09.011","article-title":"Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures","volume":"111","author":"Lepack","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib84","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib85","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109335_bib86","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib87","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/00207454.2017.1337014","article-title":"The behavioral deficits and cognitive impairment are correlated with decreased IGF-II and ERK in depressed mice induced by chronic unpredictable stress","volume":"127","author":"Li","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib88","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2008.06.023","article-title":"TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment","volume":"59","author":"Li","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109335_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109513","article-title":"A synaptic locus for TrkB signaling underlying ketamine rapid antidepressant action","volume":"36","author":"Lin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109335_bib90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2202-14-144","article-title":"Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice","volume":"14","author":"Lisowski","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib91","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0706679105","article-title":"Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib92","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib93","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuropharm.2014.10.011","article-title":"Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress","volume":"89","author":"Luo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-022-02192-6","article-title":"A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice","volume":"12","author":"Ma","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib95","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41467-017-01709-8","article-title":"TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response","volume":"8","author":"Ma","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109335_bib96","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib97","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hipo.20744","article-title":"Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons","volume":"21","author":"Magarinos","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2022.109335_bib98","doi-asserted-by":"crossref","first-page":"l7069","DOI":"10.1136\/bmj.l7069","article-title":"Esketamine is approved in Europe for treating resistant major depressive disorder","volume":"367","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2022.109335_bib99","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1139\/jpn.0905","article-title":"A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder","volume":"34","author":"McKinnon","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109335_bib102","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib103","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib104","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2011.05.047","article-title":"Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression \u2013 No influence of celecoxib treatment","volume":"134","author":"Musil","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib105","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1158\/0008-5472.CAN-05-2789","article-title":"Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells","volume":"66","author":"Nakamura","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib106","author":"Navitor"},{"key":"10.1016\/j.neuropharm.2022.109335_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2005.11.067","article-title":"The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology","volume":"397","author":"Nemoto","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib108","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1523\/JNEUROSCI.23-34-10841.2003","article-title":"Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors","volume":"23","author":"Newton","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib109","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib110","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(99)00335-3","article-title":"Repeated stress increases catalytic TrkB mRNA in rat hippocampus","volume":"267","author":"Nibuya","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib112","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnins.2016.00052","article-title":"IGF-I: a key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain","volume":"10","author":"Nieto-Estevez","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib113","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1357-2725(98)00048-X","article-title":"Insulin-like growth factor II (IGF-II)","volume":"30","author":"O'Dell","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib114","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-8-12","article-title":"Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice","volume":"8","author":"Park","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109335_bib115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1742-2094-8-179","article-title":"Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide","volume":"8","author":"Park","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109335_bib116","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1038\/tp.2014.58","article-title":"Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals","volume":"4","author":"Paterson","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib117","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1523\/JNEUROSCI.2680-04.2004","article-title":"The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology","volume":"24","author":"Pezawas","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib118","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1460-9568.2003.02513.x","article-title":"Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus","volume":"17","author":"Pham","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cercor\/bht203","article-title":"Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders","volume":"25","author":"Qi","year":"2015","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2022.109335_bib120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.181.1.660","article-title":"Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia","volume":"181","author":"Qian","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2014.08.040","article-title":"Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression","volume":"275","author":"Qiao","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113633","article-title":"The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL\/6J mice","volume":"418","author":"Rafa\u0142o-Uli\u0144ska","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib123","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/org.6.2.11687","article-title":"VEGF in the nervous system","volume":"6","author":"Rosenstein","year":"2010","journal-title":"Organogenesis"},{"key":"10.1016\/j.neuropharm.2022.109335_bib125","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1523\/JNEUROSCI.23-35-11036.2003","article-title":"Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons","volume":"23","author":"Rosenstein","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2016.06.035","article-title":"Alterration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy","volume":"205","author":"Rush","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib127","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109335_bib128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000142361","article-title":"Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients","volume":"57","author":"Sarchiapone","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib129","doi-asserted-by":"crossref","first-page":"11352","DOI":"10.1073\/pnas.0710858105","article-title":"Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus","volume":"105","author":"Segi-Nishida","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109335_bib131","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","article-title":"Hippocampal atrophy in recurrent major depression","volume":"93","author":"Sheline","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib132","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib133","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.euroneuro.2015.09.002","article-title":"Alterations in brain-deriived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist","volume":"25","author":"Shirayama","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib134","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2007.09.062","article-title":"Lithium prevents stress-induced reduction of vascular endothelium growth factor levels","volume":"429","author":"Silva","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109335_bib136","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib137","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib138","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0116-15.2016","article-title":"New hippocampal neurons mature rapidly in response to ketamine but are not required for its acute antidepressant effects on neophagia in rats","volume":"3","author":"Soumier","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2022.109335_bib139","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib140","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.08.001","article-title":"The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins","volume":"276","author":"Szczesny","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib142","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1523\/JNEUROSCI.1427-04.2004","article-title":"Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites","volume":"24","author":"Takei","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib143","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mp.2009.67","article-title":"Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis","volume":"15","author":"Taliaz","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib144","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","article-title":"Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder","volume":"169","author":"Tripp","year":"2012","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib147","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2005.09.011","article-title":"Transforming growth factor-\u03b2 signaling in brain disorders","volume":"17","author":"Vivien","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.neuropharm.2022.109335_bib148","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/jcp.24607","article-title":"IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B\/PI3K-AKT-mTOR pathway","volume":"229","author":"Wang","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib149","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1073\/pnas.0610282104","article-title":"VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants","volume":"104","author":"Warner-Schmidt","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109335_bib150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euroneuro.2021.04.010","article-title":"Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: a role of TrkB signaling","volume":"50","author":"Wei","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib151","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib152","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib153","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/mp.2016.72","article-title":"Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis","volume":"22","author":"Wise","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib154","author":"World Health Organization"},{"key":"10.1016\/j.neuropharm.2022.109335_bib155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(97)00049-0","article-title":"Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice","volume":"77","author":"Wyss-Coray","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib156","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1038\/tp.2017.95","article-title":"Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain\u2013liver axis","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib158","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.113236","article-title":"Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice","volume":"229","author":"Yang","year":"2021","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2022.109335_bib173","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","article-title":"Pro- and anti-inflammatory cytokines expression in rat\u2019s brain and spleen exposed to chronic mild stress: Involvement in depression","volume":"225","author":"You","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109335_bib160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ijnp\/pyy008","article-title":"Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide","volume":"21","author":"Youssef","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib161","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1523\/JNEUROSCI.5048-11.2012","article-title":"Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants","volume":"32","author":"Yu","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109335_bib162","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib163","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109335_bib164","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109335_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115005","article-title":"Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1R\u03b2\/PI3K\/Akt signaling pathway","volume":"288","author":"Zeng","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib167","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ijnp\/pyz048","article-title":"(R)-ketamine rapidly ameliorates the decresed spine density in the medial prefrontal cortex and hippocampus of susceptible mice after chronic social defeat stress","volume":"22","author":"Zhang","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib168","doi-asserted-by":"crossref","first-page":"pyu077","DOI":"10.1093\/ijnp\/pyu077","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109335_bib169","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109335_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109335_bib171","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109335_bib172","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200394X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082200394X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:20:33Z","timestamp":1758439233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082200394X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":173,"alternative-id":["S002839082200394X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109335","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109335"}}